Dingdang Health Completes New Buyback, Cumulative Repurchases Reach 55.35 Million Shares

Bulletin Express05-12

On 12 May 2026, Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, detailing the latest progress of its share repurchase programme.

The company bought back 13,000 ordinary shares on-market at prices between HK$0.94 and HK$0.95 per share, spending HK$12,309.70. All repurchased shares are intended for cancellation.

Despite the transaction, the issued share capital remained unchanged at 1.32 billion shares as of 12 May 2026, with no treasury shares outstanding.

Repurchase mandate utilisation • Mandate granted: 28 May 2025, authorising the company to repurchase up to 131.95 million shares. • Shares repurchased to date: 55.35 million, equivalent to 4.20 % of the share count on the mandate date. • Remaining capacity: 76.59 million shares, or roughly 58 % of the mandate.

Under Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares following the latest buyback, ending on 11 June 2026.

Since November 2025, the company has executed 69 repurchase transactions—pending cancellation—at prices ranging from HK$0.80 to HK$1.21 per share, illustrating an active capital-management strategy within its authorised limit.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1146787818?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146787818","market":"us","top_or_hot":-1,"title":"Dingdang Health Completes New Buyback, Cumulative Repurchases Reach 55.35 Million Shares","media":"Bulletin Express","content":"<p>On 12 May 2026, Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, detailing the latest progress of its share repurchase programme.</p>\n<p>The company bought back 13,000 ordinary shares on-market at prices between HK$0.94 and HK$0.95 per share, spending HK$12,309.70. All repurchased shares are intended for cancellation.</p>\n<p>Despite the transaction, the issued share capital remained unchanged at 1.32 billion shares as of 12 May 2026, with no treasury shares outstanding.</p>\n<p>Repurchase mandate utilisation  \n• Mandate granted: 28 May 2025, authorising the company to repurchase up to 131.95 million shares.  \n• Shares repurchased to date: 55.35 million, equivalent to 4.20 % of the share count on the mandate date.  \n• Remaining capacity: 76.59 million shares, or roughly 58 % of the mandate.</p>\n<p>Under Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares following the latest buyback, ending on 11 June 2026.</p>\n<p>Since November 2025, the company has executed 69 repurchase transactions—pending cancellation—at prices ranging from HK$0.80 to HK$1.21 per share, illustrating an active capital-management strategy within its authorised limit.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Completes New Buyback, Cumulative Repurchases Reach 55.35 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Completes New Buyback, Cumulative Repurchases Reach 55.35 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-12 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 12 May 2026, Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, detailing the latest progress of its share repurchase programme.</p>\n<p>The company bought back 13,000 ordinary shares on-market at prices between HK$0.94 and HK$0.95 per share, spending HK$12,309.70. All repurchased shares are intended for cancellation.</p>\n<p>Despite the transaction, the issued share capital remained unchanged at 1.32 billion shares as of 12 May 2026, with no treasury shares outstanding.</p>\n<p>Repurchase mandate utilisation  \n• Mandate granted: 28 May 2025, authorising the company to repurchase up to 131.95 million shares.  \n• Shares repurchased to date: 55.35 million, equivalent to 4.20 % of the share count on the mandate date.  \n• Remaining capacity: 76.59 million shares, or roughly 58 % of the mandate.</p>\n<p>Under Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares following the latest buyback, ending on 11 June 2026.</p>\n<p>Since November 2025, the company has executed 69 repurchase transactions—pending cancellation—at prices ranging from HK$0.80 to HK$1.21 per share, illustrating an active capital-management strategy within its authorised limit.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1146787818","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146787818","pubTimestamp":1778582592,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 12 May 2026, Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, detailing the latest progress of its share repurchase programme. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康完成新回购累计回购达5535万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"On 12 May 2026, Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, detailing the latest progress of its share repurchase programme.\nThe company bought back 13,000 ordinary shares on-market at prices between HK$0.94 and HK$0.95 per share, spending HK$12,309.70. All repurchased shares are intended for cancellation.\nDespite the transaction, the issued share capital remained unchanged at 1.32 billion shares as of 12 May 2026, with no treasury shares outstanding.\nRepurchase mandate utilisation  \n• Mandate granted: 28 May 2025, authorising the company to repurchase up to 131.95 million shares.  \n• Shares repurchased to date: 55.35 million, equivalent to 4.20 % of the share count on the mandate date.  \n• Remaining capacity: 76.59 million shares, or roughly 58 % of the mandate.\nUnder Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares following the latest buyback, ending on 11 June 2026.\nSince November 2025, the company has executed 69 repurchase transactions—pending cancellation—at prices ranging from HK$0.80 to HK$1.21 per share, illustrating an active capital-management strategy within its authorised limit.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146787818","isCrawlerRequest":true}